that the ravages of the disease could be reversed. By packaging genetic instructions for CRISPR into AAV vectors, the researchers repaired skeletal and cardiac muscle cells, either by injecting the loaded viruses into the mouse’s muscles or by delivering the viruses to the same tissues through the bloodstream. They succeeded in turning on the healthy dystrophin genes, and the treated mice even showed substantial enhancement in muscle
